1.. Background {#s1}
==============

Yeast has served as a model eukaryote for biological research for over a century. In the 'pre-sequence' era (prior to 1996), in order to isolate effects of genotype on phenotype, mutant validation required tedious backcrossing to wild-type. In the genomic era, the combination of a well-annotated genome sequence with new PCR-based gene disruption technologies made reverse genetics straightforward, allowing the construction of the Yeast Knockout (YKO~aux~) collection, the first and only genome-wide set of precise start-to-stop gene deletions comprising approximately 6000 strains representing the yeast genome \[[@RSOB160330C1],[@RSOB160330C2]\]. The YKO~aux~ collection has greatly expanded our understanding of gene function and the cellular response to perturbation through comprehensive screens performed in thousands of different environmental and drug conditions \[[@RSOB160330C1],[@RSOB160330C2]\]. As a result, in the 15 years since the completion of the YKO~aux~ deletion collection, the proportion of the genome with functional annotation has increased from approximately 30% to 90% \[[@RSOB160330C3]--[@RSOB160330C7]\].

For historical reasons an auxotrophic derivative of S288c, a *Saccharomyces cerevisiae* wild-type, was chosen as the parent strain of the YKO~aux~ collection. The auxotrophies ([table 1](#RSOB160330TB1){ref-type="table"}) were included to facilitate genetic manipulations and at the time were considered inert. A decade of functional genomic, proteomic and metabolomic studies have revealed that these auxotrophies are far from benign and have clear impacts on cellular physiology. Compared with the prototrophic parent, the YKO~aux~ genotype exhibits slower growth rates, decreased survival in starvation conditions and altered patterns of gene expression \[[@RSOB160330C9]--[@RSOB160330C15]\]. In addition to auxotrophic effects, natural variants present in the S288c parent strain manifest genotype-specific traits that include poor sporulation and increased rates of mitochondrial genome loss \[[@RSOB160330C16]--[@RSOB160330C19]\]. Furthermore, within the *S. cerevisiae* clade, S288c has been classified as an outlier both at the sequence level and by comparative phenotyping \[[@RSOB160330C4],[@RSOB160330C20]\]. Table 1.Genotypes of deletion collections used in this study.strainbackgroundgenotypesourceYKO~aux~BY4743*MATa/α his3Δ1/his3Δ1 leu2Δ0 /leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0 /ura3Δ0*Giaever *et al*. \[[@RSOB160330C2]\]; Winzeler *et al*. \[[@RSOB160330C1]\].BC~prot~BY4741*MATa can1Δ::STE2pr-SpHIS5 his3Δ1 lyp1Δ0*VanderSluis *et al*. \[[@RSOB160330C8]\].PB~prot~BY4741*MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0* + pHLUM (Addgene ID 40276)Mulleder *et al*. \[[@RSOB160330C9]\].*MATa*BY4741*MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0*Giaever *et al*. \[[@RSOB160330C2]\]; Winzeler *et al.* \[[@RSOB160330C1]\].

Two prototrophic versions of the YKO *MATa* collection have been constructed to address the potential confounding effects of auxotrophy and, importantly, enable metabolomic studies without nutrient supplementation \[[@RSOB160330C21]--[@RSOB160330C23]\]. In the first case, the 'Plasmid-Borne' (PB~prot~) prototrophic collection, auxotrophies were genetically complemented by introducing a single-copy ARS-CEN plasmid carrying wild-type copies of the *HIS3*, *LEU2*, *URA3* and *MET17* genes (pHLUM) \[[@RSOB160330C9]\]. In the second 'Backcrossed' (BC~prot~) collection, the auxotrophic markers were repaired using a synthetic genetic array (SGA)-based methodology \[[@RSOB160330C24]\] by backcrossing to a strain prototrophic for the auxotrophic markers (*LEU2*, *URA3* and *MET17* from *S. cerevisiae* and *HIS5* from *Schizosaccharomyces pombe*) and carrying deletions in the arginine (*CAN1)* and lysine (*LYP1)* transporters \[[@RSOB160330C25]\] (ACY742:*MATα can1Δ::STE2pr-SpHIS5 his3Δ1 lyp1Δ0*). Prototrophic *MATa* haploid deletion strains capable of growing on minimal media (MM) were then selected ([table 1](#RSOB160330TB1){ref-type="table"}).

A powerful experimental feature of the YKO~aux~ collection is the presence of two unique 20-base-pair sequences linked to each deletion strain that serve as unique strain identifiers. These tags, or barcodes, enable the fitness of each strain to be analysed in parallel by pooling strains in competitive growth assays. The relative abundance of barcodes representing each strain is then quantitatively assessed by microarray signal intensity \[[@RSOB160330C26],[@RSOB160330C27]\] or by counting barcode read-outs by sequencing (Bar-seq) \[[@RSOB160330C28]--[@RSOB160330C31]\]. In addition to fitness profiling, barcodes provide protection from inevitable mix-ups in strain inventory. We took advantage of the unbiased metric of the molecular barcodes to systematically characterize in parallel the phenotypic behaviour of the PB~prot~ and BC~prot~ deletion sets with the original YKO~aux~ collection by performing chemogenomic and environmental fitness profiling in diverse drug and media conditions. We chose the YKO~aux~ homozygous deletion collection for our reference collection after confirming equivalent fitness profiles to the *MATa* haploid collection in a number of synthetic dropout conditions using Bar-seq (electronic supplementary material, figure S1). This choice was due to the availability of more than 3000 YKO~aux~ screens produced by our laboratory in that background \[[@RSOB160330C32]\]. Comparative analysis of the resulting fitness profiles reveals both genotypic (biological) and technical effects of the methodology used to restore prototrophy. Here, we highlight the advantages and disadvantages of each collection for the interrogation of specific biological processes, including findings of significant strain loss and the inability to fully restore wild-type behaviour.

2.. Results {#s2}
===========

2.1.. Genetic roster of each deletion collection {#s2a}
------------------------------------------------

We constructed a robust metric for strain presence for the comparison of two prototrophic collections with the YKO~aux~ collection after generating independent pools of all deletion strains (Material and methods). Strain presence was quantified by microarray signal intensities following five generations of growth in synthetic complete (SC) media. The distribution of signal intensities was significantly different for each collection (Kolmogorov--Smirnov *p*-value \< 0.05, electronic supplementary material, figure S2). To allow a fair comparison of the fitness profiles obtained, background thresholds were independently determined for each pool using a two-component Gaussian mixture model (Material and methods). The need to independently assess background thresholds was not unexpected; the distribution of fluorescence intensity for a given pool shifts towards lower values as the number of specifically bound probes decreases. Strains hybridizing below these thresholds were considered to be absent from their respective pool and were removed prior to any downstream analysis. A total of 4776 gene deletions were present in at least one pool and 77% (3690) of those were present in all three collections. The original YKO~aux~ collection represented the non-essential yeast genes most comprehensively with 96% (4594) of deletion strains, compared with 89% (4272) in the PB~prot~ collection and 82% (3894) in the BC~prot~ collection ([figure 1](#RSOB160330F1){ref-type="fig"}*a*; electronic supplementary material, Additional File S1). Figure 1.Genetic knockout strain make-up of the three deletion collections. (*a*) Venn diagram depicting deletion strains present in each of the three deletion collections in SC media (YKO~aux~, BC~prot~, PB~prot~) compared with the gene universe of strains present in at least one collection (4776). Table compares the number of strains missing (i.e. are below the background threshold) from each collection, and the subset of these strains that exhibit slow growth \[[@RSOB160330C33]\]. (*b*) Pie charts illustrating the proportion of 849 established slow-growing deletion strains \[[@RSOB160330C33]\] absent/present in each collection. Relative proportions of missing strains from each collection were comparable to a similar study \[[@RSOB160330C34]\]. (*c*) GO enrichment map of the 882 gene deletion strains absent in the BC~prot~ collection relative to the universe in (*a*). The two most highly enriched biological processes were mitochondrial RNA metabolism (*q* = 7.08 × 10^−5^) and amino acid biosynthetic processes (*q* = 2.35 × 10^−5^). Different node colours represent different GO biological processes; node size is proportional to the number of genes present in each GO term enrichment. The width of each edge is proportional to the degree of gene overlap between GO terms.

To highlight the differences between gene rosters of strains present or absent from each collection, pairwise combinations were evaluated for shared and unique functional enrichments. The most surprising difference was the 882 strains below the limit of detection missing from the BC~prot~ collection, 376 of which were also absent from the PB~prot~ collection. Of the 849 deletion strains annotated as required for optimal growth \[[@RSOB160330C33]\], 54% and 28% were missing strains from the BC~prot~ and PB~prot~ collections, respectively, compared with 11% for the YKO~aux~ collection ([figure 1](#RSOB160330F1){ref-type="fig"}*b*). Overall, the 882 genes absent in BC~prot~ were significantly enriched for amino acid and nucleotide biosynthetic pathways (*q* = 2 × 10^−5^) in addition to all aspects of mitochondrial function ([figure 1](#RSOB160330F1){ref-type="fig"}*c*; electronic supplementary material, Additional File S2). The absence of these strains was anticipated as the majority are slow or inviable in MM \[[@RSOB160330C33]\] and would, therefore, have been selected against during strain construction.

Of the 76 strains absent only in the YKO~aux~, no enrichment for biological processes was observed. Moreover, 60% (45) of these strains were never successfully constructed as diploids by the YKO deletion project. A small subset of strains was absent from the YKO~aux~ and BC~prot~ collections and explicitly required for mating (*COA1*, *GPA1*, *MSL1*, *SIR2*, *SIR3*, *SRV2*, *STE2*, *STE4*, *STE5*, *STE7*, *STE11*, *STE14*) \[[@RSOB160330C1],[@RSOB160330C2],[@RSOB160330C35],[@RSOB160330C36]\], reflecting the inability of these strains to survive the mating step during construction. The relative proportions of strains present in SC media shown here were consistent with those following five generations of growth in rich media (YPD) (electronic supplementary material, figure S3). Barcode sequencing (Bar-seq) of select samples in this study was compared with published data from our laboratory and others (electronic supplementary material, figure S4) \[[@RSOB160330C29],[@RSOB160330C30]\], providing an independent measure of strain presence which recapitulated the microarray data (electronic supplementary material, Additional Files S3 and S4).

2.2.. Comparative fitness profiling {#s2b}
-----------------------------------

Following assessment of strain presence, we next characterized the phenotypic behaviour of each collection in competitive fitness assays performed in diverse stress conditions including (i) 13 nitrogen and nucleotide-limiting conditions, (ii) the DNA-damaging agent cisplatin and (iii) mitochondrial stress conditions: the oxidative phosphorylation uncoupling agents FCCP, CCCP and growth in obligate respiratory conditions (YPG) ([table 2](#RSOB160330TB2){ref-type="table"}; electronic supplementary material, Additional File S3). For all assays, deletion pools were grown robotically and harvested after five generations of growth (Material and methods). Table 2.Drug and media conditions assayed per deletion collection by microarray. \*MM condition for YKO~aux~ was supplemented with histidine (20 mg l^−1^), leucine (30 mg l^−1^), methionine (20 mg l^−1^) and uracil (20 mg l^−1^). Additional Bar-seq experiments were done for the YKO~aux~ (ARG--, TRP--, LYS--, SC) and *MATa* (ARG--, TRP--, SC) with three and four replicates per condition, respectively (electronic supplementary material, Additional File S4).controlconditionYKO~aux~BC~prot~PB~prot~SCcontrol333SCADE--333SCARG--333SCHIS--033SCLEU--033SCLYS--323SCMET--333SCSER--323SCTHR--323SCTRP--333SCURA--033SCMM\*345SCMM + URA011YPDcontrol111412YPDcisplatin, DNA cross-linking agent343YPDCCCP, protonophore inhibitor of oxidative phosphorylation333YPDFCCP, protonophore inhibitor of oxidative phosphorylation333YPDPYRQ, novel quinolone compound, PCID 16001701444YPDYPG, obligate respiratory244

### 2.2.1.. Nutrient-limiting conditions {#s2b1}

Fitness profiles readily identify all genes required in the corresponding biosynthetic pathways when assayed in conditions lacking a specific amino acid, purine or pyrimidine \[[@RSOB160330C37]\]. Both the YKO~aux~ and the PB~prot~ collections recapitulated the established biosynthetic pathways with only minor differences observed between collections (Pearson\'s correlation *r* = 0.91--0.96) in adenine (ADE--), arginine (ARG--), methionine (MET--), lysine (LYS--) and tryptophan (TRP--) dropout screens ([figure 2](#RSOB160330F2){ref-type="fig"}; electronic supplementary material, figure S5*a--d*). The conditions that prohibit screening of the YKO~aux~ collection, including histidine (HIS--), leucine (LEU--) and uracil (URA--) dropout media, were of the greatest interest because of the paucity of functional annotations for these biosynthetic pathways. In these conditions, expression of the genes carried on the PB~prot~ ARS-CEN vector is explicitly required and fitness profiling of the PB~prot~ revealed a unique gene signature that described genes required for plasmid and mini-chromosome maintenance ([figure 3](#RSOB160330F3){ref-type="fig"}). The fact that the histidine--leucine--uracil (HLU) fitness signature was not observed in MET-- media despite requiring active expression of *MET17* from the ARS-CEN vector ([figure 2](#RSOB160330F2){ref-type="fig"}; electronic supplementary material, figure S5) is consistent with methionine\'s role in the regulation of cell cycle progression. Insufficient levels of intracellular methionine (and its downstream product, cysteine) signal cell cycle arrest at G1/start \[[@RSOB160330C38]--[@RSOB160330C40]\] until a sufficient level of metabolites is reached to allow successful progression of the cell cycle. During methionine depletion, this cell cycle delay may alleviate the fitness defects (FDs) observed for HIS-- LEU-- and URA-- in the HLU signature. If this interpretation is correct, we expect to observe a similar gene signature in any condition that impinges on histidine, leucine or uracil biosynthetic pathways. Figure 2.Comparative fitness profiling of the YKO~aux~ and PB~prot~ collections in synthetic dropout media. Hierarchical clustering of median fitness defect (FD) scores for deletion strains across three replicates observed for YKO~aux~ (blue) and PB~prot~ (green) in five synthetic dropout conditions (ADE--, ARG--, MET--, LYS--, TRP--) (log~2~ ratio ≥1 in at least one condition). The labelled clusters list the deletion strains with FDs in the corresponding dropout media. Figure 3.Characteristic PB~prot~ fitness signature observed in conditions requiring expression from the auxotrophy-complementing HLUM plasmid. Hierarchical clustering of median FD scores for deletion strains (log~2~ ratio ≥1 in at least one experiment) for the PB~prot~ collection in synthetic dropout media (ADE--, ARG--, HIS--, LEU--, LYS--, MET--, SER--, THR--, TRP--, URA--). Characteristic deletion strains belonging to the HLU (shared in HIS--, LEU-- and URA-- conditions) plasmid signature are boxed in black. Inset: GO biological process enrichment for the HLU signature. Node colours represent different GO biological processes; node size is proportional to the number of genes present in each GO term enrichment. Edge widths in the network represent the fraction of overlap between genes in related GO terms.

The HLU fitness signature is defined by 73 core genes and revealed an enrichment for biological processes that involved a response to DNA replicative stress including: (i) nuclear division (*q* = 2.75 × 10^−12^), (ii) regulation of mitotic sister chromatid segregation (*q* = 2.54 × 10^−11^) and (iii) M-phase of mitotic cell cycle (*q* = 1.02 × 10^−12^) ([figure 3](#RSOB160330F3){ref-type="fig"}, inset; electronic supplementary material, Additional File S5, <https://goo.gl/AnUx9o>). Many of these genes were originally identified in classic genetic screens for chromosome instability \[[@RSOB160330C41]\], including *CLB5, CSM3, CTF4*, *CTF19*, *ELG1, IML3, MCM16*, *MCM21, MRC1, NUP120* and *RTT109*.

To test if we could correct for this confounding effect and allow the identification of genes specifically sensitive in HIS--, LEU-- and URA-- screens, fitness scores were recalculated using the HLU gene signature as the reference condition (Material and methods). Following this data transformation, resulting fitness profiles clearly identified genes required in these biosynthetic pathways ([figure 4](#RSOB160330F4){ref-type="fig"}*a--c*). The histidine profile revealed all genes required for biosynthesis, as well as the general amino acid control (GAAC)-regulated *BAS1* transcription factor required specifically in adenine- and histidine-limiting conditions ([figure 4](#RSOB160330F4){ref-type="fig"}*a*). Similarly, the uracil profile identified *URA1*, *URA2* and *URA5* as required for uracil biosynthesis in addition to the *PPR1* transcriptional activator of the *de novo* pyrimidine biosynthesis pathway. As *URA4* was a member of the common HLU signature, it was not identified as specifically being required in the uracil dropout condition ([figure 4](#RSOB160330F4){ref-type="fig"}*b*). The presence of these auxotrophic strains in the PB~prot~ collection was unexpected. We have subsequently learned that the construction of the PB~prot~ collection \[[@RSOB160330C9]\] involved the initial selection of transformants on *either* histidine *or* uracil single dropout conditions that was followed by passaging on MM (M. Ralser 2016, personal communication). The ultimate reason for the presence of auxotrophic strains in the PB~prot~ collection, therefore, remains to be determined. Figure 4.Fitness profiles of prototrophic collections in HIS--, LEU-- and URA-- dropout conditions. Fitness profiles for the PB~prot~ and BC~prot~ deletion collections in (*a*) HIS--, (*b*) URA-- and (*c*) LEU-- after five generations of growth. Left panel: FDs observed for the PB~prot~. Middle panel: PB~prot~ fitness profiles after correcting for the 73 genes in the HLU signature (Material and Methods), revealing histidine-, leucine- and uracil-specific effects. Right panel: fitness profiles observed for the BC~prot~ collection in the same condition. Red dashed line indicates the significance threshold of an FD score of 1.0.

Compared with *HIS3* and *URA3* auxotrophy, deletion of *LEU2* is considered more detrimental to cellular physiology, exhibiting slower growth rates \[[@RSOB160330C9]\] and a decreased rate of survival in starvation conditions \[[@RSOB160330C30],[@RSOB160330C42]\]. In leucine dropout conditions, PB~prot~ FDs included *HTD2* from the mitochondrial fatty acid biosynthetic pathway (FASII), genes involved in protein lipoylation (*AIM22, GCV3*, *LIP2*), and *LPD1* and *PDX1* encoding the mitochondrial dihydrolipoyl dehydrogenase complex. Consistent with these results, the BC~prot~ leucine profile reported *PDX1*, as well as *MPC1,* a subunit of the mitochondrial pyruvate carrier (*MPC1/MPC2*), and the transcription regulators *LEU3* and *LEU4*. As such, the strains incurring FDs in both collections are deleted for genes that regulate beyond those explicitly required for leucine biosynthesis ([figure 4](#RSOB160330F4){ref-type="fig"}*c*). These observations are of particular interest as leucine is thought to play a role in central metabolism, including iron--sulfur cluster biogenesis, mitochondrial genome maintenance, and regulation of acetyl-CoA between mitochondrial and cytoplasmic compartments \[[@RSOB160330C43]\]. The FASII pathway is thought to provide the octanoic acid required for biosynthesis of the cofactor lipoic acid (*AIM22, GCV3*, *LIP2*), which in turn is required by the mitochondrial pyruvate dehydrogenase complex (*LPD1, PDX1*), suggesting that the leucine biosynthetic pathway plays a substantial role in maintaining healthy mitochondrial function \[[@RSOB160330C33]\]. To date, however, the exact role of the FASII pathway has not been directly demonstrated and, therefore, the relationship between leucine metabolism and the FASII pathway, which cannot be evaluated in the YKO~aux~ collection due to leucine auxotrophy, serves to highlight an advantage of the prototrophic collections.

Because the majority of deletion strains required for amino acid and nucleotide biosynthesis are missing from the BC~prot~ collection, the resulting FDs were observed only in strains that are specifically compromised for growth in dropout, but not in MM (on which the prototrophic deletion strains were selected). Reported fitness scores included several strains deleted for genes in the GAAC system, including *ARO3*, *ARO4*, *GCN3* and *GCN20,* also observed in the YKO~aux~ and PB~prot~ collections (electronic supplementary material, figure S5). *GCN4,* however, was present only in the YKO~aux~ collection due to the requirement for this important transcriptional activator during the nutrient selection steps required for the construction of both prototrophic collections.

A unique BC~prot~ FD observed was for the strain deleted for *CPA1*, a gene required for arginine biosynthesis. The *cpa1Δ* BC~prot~ strain exhibited severe FDs in all conditions *except* in minimal and uracil dropout media (electronic supplementary material, figure S6). By contrast, the YKO~aux~ and PB~prot~ *cpa1Δ* strains were sensitive only in arginine dropout media ([figure 5](#RSOB160330F5){ref-type="fig"}*a*). These results were observed using both the YKO~aux~ and the *MATa* collection (electronic supplementary material, figure S7). Because the *can1Δ* (encoding the major arginine transporter) in the genetic background of the BC~prot~ collection ([table 1](#RSOB160330TB1){ref-type="table"}) is synthetically lethal with genes in the arginine pathway, we investigated how the *cpa1Δ* strain was able to survive selection on MM during strain construction and why it manifested such an unusual phenotype. An explanation was provided by a classical biochemical study \[[@RSOB160330C45]\] examining the regulation of pyrimidine biosynthesis and the two genes, *CPA1* and *URA2,* that encode carbamoyl-phosphate synthase (CPS) ([figure 5](#RSOB160330F5){ref-type="fig"}*b*, --uracil). The activity of either is sufficient to supply the metabolic product carbomyl phosphate, required for both arginine and pyrimidine biosynthesis. In MM, *URA2* is expressed and active, allowing the *cpa1Δ* strain to grow normally. Addition of uracil to the media represses the *URA2* enzyme through negative feedback, and *cpa1Δ* is inviable due to the absence of any carbomyl phosphate synthetase activity ([figure 5](#RSOB160330F5){ref-type="fig"}*b*, +uracil). Viability can be rescued by adding arginine to the media as evidenced by the PB~prot~ *cpa1Δ* ([figure 5](#RSOB160330F5){ref-type="fig"}*c*). However, the BC~prot~ *cpa1Δ* strain is also deleted for *CAN1* (encoding the major arginine transporter), which prohibits rescue even in the presence of excess arginine ([figure 5](#RSOB160330F5){ref-type="fig"}*c*). This *can1Δ cpa1Δ* negative genetic interaction therefore explains the FDs observed for the BC~prot~ *cpa1Δ* in all conditions where uracil is present. Interestingly, in a previous study, a BC~prot~-specific *cpa1Δ* FD (as well as the *cpa1Δ_uORF*) was observed when grown in rich media with dextrose (YPD) that was alleviated in rich media with galactose providing the sole carbon source (YPGal) (log ratio −3.5 and −2.9, respectively) \[[@RSOB160330C28]\], suggesting a depression of the pyrimidine pathway in line with the known requirement for UTP in YPGal metabolism. Taken together, the can1(deletion symbol)cpa1(deletion symbol) phenotypes described above are consistent with the need for an active pyrimidine biosynthesis pathway in order to rescue these strains\' FDs (electronic supplementary material, figure S8). Figure 5.Fitness profiling reveals genotype-specific biology. (*a*) Fitness profiles in ARG-- for the YKO~aux~, PB~prot~ and BC~prot ~deletion collections. Orange labels: FDs in genes known to be required for arginine biosynthesis. Red dashed line indicates the FD significance threshold of 1.0. (*b*) Schematic depiction of the cross-talk between the arginine and pyrimidine biosynthetic pathways via the metabolite carbomyl phosphate. In the absence of arginine and uracil supplementation (red), the *cpa1Δ* strain grows normally by 'borrowing' carbamoyl phosphate produced by the pyrimidine biosynthetic pathway. If uracil is added (green), the pyrimidine pathway is repressed, and growth of the *cpa1Δ* strain is prohibited, phenocopying the synthetic lethal interaction of *ura2Δ* with *cpa1Δ*. (*c*) Testing of collection-specific phenotypes observed for the *cpa1Δ* strain by individual strain analysis. The PB~prot ~and BC~prot ~*cpa1Δ* strains grow normally in minimal media (MM), and neither grows in the presence of exogenous uracil (MM + Ura). Arginine amounts present in standard SC media (86 mg ml^−1^) is sufficient to rescue the PB~prot ~*cpa1Δ* phenotype (SC), as is true for the YKO~aux ~*cpa1Δ* strain (data not shown). By contrast, even arginine concentrations 150× higher than in SC (1.3 × 10^4^ mg ml^−1^, MM + Ura + Arg) are insufficient to fully rescue the BC~prot ~*cpa1Δ* strain due to the deletion in *CAN1* (encoding the major arginine transporter) present in the BC~prot~ genetic background.

### 2.2.2.. Drug and small-molecule stress conditions {#s2b2}

Results from chemogenomic profiling of the DNA-cross-linking agent cisplatin for all three collections were consistent with established mechanisms and previous genome-wide fitness studies \[[@RSOB160330C46]--[@RSOB160330C48]\]. Strains exhibiting drug sensitivity in all three collections were significantly enriched for specific DNA damage response (DDR) processes that included, for example, nucleotide excision repair (NER) (*RAD1, RAD2, RAD4, RAD10, RAD14*), homologous recombination repair (HRR) (*RAD51, RAD55, RAD59*), post-replication repair (PRR) (*RAD5, RAD18*), translesion synthesis (TLS) (*REV1, REV3*) and *PSO2,* which is required for repair of cisplatin-induced inter-strand cross-links ([figure 6](#RSOB160330F6){ref-type="fig"}*a*). Interestingly, *HIS5* appears with a significant FD in the PB~prot~, but not in the YKO~aux~ or BC~prot~ profiles ([figure 6](#RSOB160330F6){ref-type="fig"}*a*). As there is cross-talk between the histidine and adenine pathways, it is possible that there is an impact on histidine biosynthesis during DDR. In addition, of the 36 genes involved in DNA damage with a significant FD score in at least one collection, approximately 60% (22) exhibit slow growth only in YPD but not in MM. Reflecting the ability of the PB~prot~ and BC~prot~ to maintain these strains during collection construction in MM, approximately 75% of these genes were present in those two collections, compared with approximately 25% in the YKO~aux~ collection. Figure 6.Comparative chemogenomic fitness profiling. Fitness profiles of the median FD scores across three replicates for the YKO~aux~, PB~prot~ and BC~prot~ deletion collections in (*a*) the DNA cross-linking agent cisplatin, (*b*) the proton ionophore FCCP and (*c*) a novel quinolone compound (PCID 16001701) \[[@RSOB160330C32]\]. Red, blue, green labels: FDs observed for strains deleted for genes annotated in DDR (DNA damage response), adenine biosynthesis and mitochondrial processes, respectively. Red dashed line indicates an FD score of 1.5.

In *S. cerevisiae,* approximately 1000 of all 6000 genes participate in mitochondrial processes and serve crucial, evolutionarily conserved cellular functions. We therefore focused on conditions that perturb mitochondrial function to compare deletion collections. Fitness profiles of the three collections in low doses of the mitochondrial membrane potential poisons CCCP and FCCP as well as growth in obligate respiratory media (YPG, where glycerol provides the carbon source) exhibited strong enrichment in both YKO~aux~ and PB~prot~ profiles for mitochondrial translation and respiration (*q* \< 1 × 10^−17^ in all conditions). By contrast, the BC~prot~ fitness response was relatively sparse; no enrichment was observed in any of the mitochondrial stress conditions, reflecting the significant proportion of mitochondrial deletion strains missing in that collection ([figure 6](#RSOB160330F6){ref-type="fig"}*b*).

Challenging the deletion collections with a compound of unknown mechanism provides an unbiased stress for comparing the three collections. The fitness signature of a cationic quinolone (PCID 16001701) previously screened by our laboratory \[[@RSOB160330C32],[@RSOB160330C49]\] was highly correlated with adenine dropout fitness profiles (electronic supplementary material, figure S5*a*). We reproduced this gene signature in the YKO~aux~ which was supported by a similar profile in PB~prot~, identifying adenine and folic acid biosynthesis genes (*ADE1*, *ADE3*, *ADE4*, *ADE6*, *SHM2, THI3*) ([figure 6](#RSOB160330F6){ref-type="fig"}*c*). The profiles from these two collections suggest the compound acts via a mechanism that requires adenine biosynthesis directly or indirectly. The BC~prot~ profile was uninformative with respect to the mechanism of action of this compound.

3.. Discussion {#s3}
==============

Our comparative, genome-wide fitness survey of the original YKO~aux~ and two prototrophic versions of the collection across diverse environmental and stress conditions revealed several surprising findings relevant to applying these collections in gene function studies. First, while both the PB~prot~ and BC~prot~ satisfy the definition of prototrophy, 'that a cell or organism has the same nutritional requirements as wild- type', the benefits of prototrophy are offset by the cost of losing informative deletion strains. For example, the selection on MM during the construction of the prototrophic collections by definition prohibits future study in these basic nutrient conditions, as informative strains unable to grow will be selected against. Our study demonstrates that these required selection steps introduced both predictable and unexpected biases. Specifically, only approximately 25% of the 882 strains missing from the BC~prot~ collection were anticipated based on these selection steps. Of the remaining 670 strains, 57% (380) were also missing from the PB~prot~ collection, about half of which were identified as slow growers. To avoid misinterpretation in analysing fitness profiles, it is important to be aware of the biological processes associated with these missing strains. While the repair of the YKO auxotrophies by genetic complementation in PB~prot~ was more effective than backcrossing to a prototrophic strain (with respect to strain loss), it was not neutral. Phenotypic differences between episomal and integrated genetic complementation are well documented \[[@RSOB160330C50],[@RSOB160330C51]\]. We therefore expect that, despite our ability to successfully correct for a well-defined HLU signature, unanticipated episomal effects are likely to occur that will escape detection. By contrast, though the BC~prot~ collection restored prototrophic markers to their native location (with the exception of the *HIS3* orthologue from *S. pombe* from a non-*HIS3* promoter), the *CAN1* and *LYP1* deletions present in the genetic background also introduced biases, as demonstrated for the *cpa1Δ can1Δ* synthetic lethal phenotype. These effects disrupt a key feature of competitive fitness assays---namely that the relative strain abundance in the starting pool is approximately equal. Nutritional selection steps skew this initial distribution, particularly when multiple strain passages are part of the construction methodology. As a result, the ability to detect FDs becomes more difficult, as reflected by the divergent background thresholds and lower signal intensity distributions of the prototrophic collections, compared with the YKO~aux~ collection (electronic supplementary material, figure S2).

The unexpected liabilities present in the prototrophic collections underscore that highly engineered versions of YKO~aux~ deletion collections are more constrained than generally assumed. Informative strains lost from the BC~prot~ collection (approx. 900 strains) share significant biological enrichment for genes involved in mitochondrial processes that compromise the ability to interrogate these processes ([figure 1](#RSOB160330F1){ref-type="fig"}*c*). Consistent with this finding, we found that this set of strains was also absent in the *MATa* haploid SGA. The SGA collection serves as the starting point for the study of synthetic genetic interactions \[[@RSOB160330C52]\], yet approximately 1800 total strains are not detectable by barcode microarray hybridization signal (electronic supplementary material, figure S9), limiting the biological space surveyed by SGA and related deletion collections requiring sequential selective pinning assays. Nonetheless, the value of these and other collections and technologies in providing biological insight beyond the scope of the original YKO is indisputable.

The ability to perform such a precisely genetically controlled study on three genotypically distinct deletion collections in *S. cerevisiae* is not currently feasible in other systems. Our results therefore may provide insight into fundamental principles of genotype-by-environment relationships. For example, although the concept of robust genetic buffering is pervasive in the literature (primarily from the systematic study of digenic interactions), our results also suggest that condition-dependent cellular responses (i.e. phenotype) are greatly influenced by genotype.

The experimental design and assay constraints described here may help guide screens in other organisms and cell lines as they become tractable using CRISPR and other genome-editing techniques. Systematically benchmarking genomic libraries will be critical to establishing and maintaining the quality of functional and phenotypic gene annotations. Finally, we hope our study will serve to encourage and guide the design of future yeast deletion collections, most notably the need to move beyond derivative YKO~aux~ libraries to the de novo construction of a truly prototrophic collection.

4.. Conclusion {#s4}
==============

This work underscores the degree to which systematic genetics and genomics has advanced our understanding of genotype--phenotype relationships. The resolution of comparative fitness profiling is highly sensitive, providing detailed biological insight and revealing methodological biases inherent in strain construction. Furthermore, this work demonstrates that despite differences in protocols, laboratories and experimental read-out, the results presented here can readily be extended to meta-analyses. We hope that these results encourage systematic comparative genomics of more divergent yeast collections such as those described for pseudo-filamentous or enological strains \[[@RSOB160330C53],[@RSOB160330C54]\] and closely related human pathogens \[[@RSOB160330C55]\].

5.. Material and methods {#s5}
========================

5.1.. Yeast deletion strains and media preparation {#s5a}
--------------------------------------------------

The YKO~aux~ and *MATa* deletion collections are from the original stock centre of the *Saccharomyces* Genome Deletion Project \[[@RSOB160330C1]\], curated and maintained by Angela Chu at the Stanford Genome and Technology Center. The PB~prot~ \[[@RSOB160330C9]\] and BC~prot~ \[[@RSOB160330C25]\] deletion collections were kindly provided by the Ralser and Caudy laboratories. Synthetic complete and amino acid dropout media were purchased from Sunrise Science Products. The curators of Saccharomyces Genome Database (SGD) \[7\] provided the data that 76% of the phenotypic annotations (111 504 out of a total 146 128) were derived from the YKO (personal communication, March 2017).

5.2.. Deletion pool construction {#s5b}
--------------------------------

The diploid YKO~aux~, haploid *MATa*, BC~prot~ and PB~prot~ collections were pinned (S&P Robotics Inc., BM3- BC) from thawed glycerol stocks in 384-well or 96-well plates, respectively, onto rich YPD media (20 g l^−1^ bacto peptone, 10 g l^−1^ yeast extract, 20 g l^−1^ bacto agar and 20 g l^−1^ glucose), and recovered for 48--72 h at 30°C until colonies reached 2 mm in diameter. Plates were flooded with 12 ml liquid media and yeast cells were soaked and scraped off the plates. Resuspended cells from each plate were pooled in a sterile flask, and the final OD~600~ of the pool was adjusted to a final 50 OD~600~ ml^−1^. DMSO was added to the pool to a final concentration of 7% (v/v), mixed well, and the final pool aliquoted into individually capped PCR tubes and stored at −80°C.

5.3.. Competitive fitness assays: synthetic media screens {#s5c}
---------------------------------------------------------

Pooled deletion strains were diluted to starting OD~600~ of 0.0625 in 700 μl and were grown in duplicate wells on the same plate for five doublings in a Tecan Genios (Tecan Systems, Inc.) spectrophotometer at 30°C. Cells were manually harvested (synthetic media and drug screens) or automatically collected (YPG screens) using a Packard Multiprobe (PerkinElmer) liquid handler and stored at −20°C in a 48-well plate for no longer than 1 day. For the amino acid dropout experiments, each pooled collection was grown in SC medium or rich medium (YPD) as the control condition, and synthetic medium with an individual amino acid of interest dropped out as the experimental condition. For the YPG experiments, 3% glycerol was the experimental condition and YPD was the control condition.

5.4.. Competitive fitness assays: chemical screens {#s5d}
--------------------------------------------------

Samples were subject to the same starting OD~600~ and doubling times as above. Screening concentrations for each compound (cisplatin (Toronto Research Chemicals), PCID 16001701 (ChemDiv), CCCP (Sigma), FCCP (Sigma)) were determined by analysing dose--response curves on wild-type auxotrophic BY4743 or prototrophic BY4743 transformed with p*HLUM* to determine the concentration that inhibits BY4743 growth by 15--20% (200 µM for cisplatin, 125 µM for PCID 16001701, 32 µM for CCCP and 6 µM for FCCP). YPD plus solvent (2% DMSO) was used as the controls with the exception of cisplatin (2% H~2~O).

Following growth, genomic DNA was extracted from cell pellets using the YeastStar Genomic DNA Kit (Zymo Research, catalogue \#D2002) and quantified using the NanoDrop 2000 (Thermo Scientific). Uptag and downtag barcodes were amplified separately, pooled and hybridized to the Affymetrix TAG4 microarray (Genflex tag16K array) as previously described \[[@RSOB160330C27],[@RSOB160330C32]\].

5.5.. Array normalization and preprocessing {#s5e}
-------------------------------------------

Each probe on the TAG4 barcode microarray (Genflex tag16K array, Affymetrix) is represented by five replicate features dispersed across the array that allow hybridization artefacts to be identified and corrected. Hybridization artefacts were removed using a previously described masking algorithm \[[@RSOB160330C27]\]. Independent sample sets were defined by collection and growth media (six sets in total, PB~prot~, BC~prot~ and YKO~aux~ in SC and YPD). To define background thresholds independently for each pool, we used a two-component Gaussian mixture model to fit the distribution of tags in the control arrays in each set (R v. 3.2.2, mixtools package, v. 1.0.4) \[[@RSOB160330C56],[@RSOB160330C57]\]. The estimated components represent tags that successfully hybridized (present) and tags that did not hybridize (absent). We used the posterior distribution of the assignment of a tag to the present or absent component to select present tags for further analysis in non-control array data. To be called as present, all tags representing an ORF had to have a posterior value greater than 0.5 in all of the control replicates.

During the course of this study, we recognized that the homozygous BY4743 pools we used in this study were missing a subset of 143 strains due to a technical error that occurred during pool construction. These strains are part of the YKO v. 2.0 (<http://www-sequence.stanford.edu/group/yeast_deletion_project/ykov2.html>) that had already been added to the *MATa* versions of the collections available from commercial suppliers. Because our homozygous strain collection is derived from the original Stanford collection, these strains were omitted during shipment. In our study of the homozygous collection, the presence of these strains is supported by more than 3000 experiments \[[@RSOB160330C32]\]. This small subset of strains was used only for the purposes of the Venn diagram presented in [figure 1](#RSOB160330F1){ref-type="fig"}*a*.

Next, tags designated as present upstream (uptags) and downstream (downtags) of the drug resistance cassette were normalized separately to their overall median across arrays within each of the six sets (the PB~prot~, BC~prot~ and YKO~aux~ collections in SC and YPD media). The uptag and downtag were collapsed into a single value by selecting the 'best' tag defined by the tag that exhibited the lowest coefficient of variation across the control replicates for each set. Biological replicates for each condition were performed in triplicate and batch corrected for technical variation using the ComBat function available in the R sva package (v. 3.14.0) \[[@RSOB160330C58]\].

5.6.. Fitness defect scores {#s5f}
---------------------------

FD scores for each tag in each set were calculated by subtracting the log~2~ intensity of each individual tag in the treatment condition from the corresponding median in the control conditions. To estimate strains exhibiting significant FD scores, values from independent triplicate experiments were fit to a linear model; *q-*values (threshold *q* \< 0.05) were obtained from the resulting *p-*values using the Benjamini---Hochberg method to adjust for multiple comparisons \[[@RSOB160330C59]\]. Pearson\'s correlations between the YKO~aux~ and PB~prot~ collections were calculated using deletion strains that had an FD score greater than one in at least one common nutrient-limiting condition. Fitness profiles for each condition (figures [2](#RSOB160330F2){ref-type="fig"}[](#RSOB160330F3){ref-type="fig"}[](#RSOB160330F4){ref-type="fig"}[](#RSOB160330F5){ref-type="fig"}--[6](#RSOB160330F6){ref-type="fig"}; electronic supplementary material, figures S1, S5, S7 and S8, Additional File S4) were summarized by the median value across triplicate FD scores. Similarly, the PB~prot~ HLU signature was defined by the median FD across the HIS--, URA-- and LEU-- replicates. To identify specific FDs in HIS--, URA-- and LEU-- dropout conditions, the PB~prot~ HLU common signature was subtracted from each of the HIS--, LEU-- and URA-- dropout conditions. To compare the overlap between FDs observed in Bar-seq versus those observed in the microarray analysis, only the experiments common to both were used (electronic supplementary material, Additional File S4).

5.7.. GO enrichment {#s5g}
-------------------

GO enrichment analysis was performed in C[ytoscape]{.smallcaps} (v. 3.3) \[[@RSOB160330C60]\] with the ClueGO plugin (v. 2.2.5) \[[@RSOB160330C61]\]. Enrichments for strains missing in the BC~prot~ collection ([figure 1](#RSOB160330F1){ref-type="fig"}*c*) and deletion strains in the HLU signature ([figure 3](#RSOB160330F3){ref-type="fig"}, inset) were compared with the gene universe (defined by the set of strains present in at least one of the three deletion collections). GO biological process terms with less than five genes or greater than 300 genes were excluded from the enrichment analysis. A right-sided hypergeometric test was used with a Bonferroni step-down correction and a minimum *p-*value of 0.0005 with a kappa score threshold of 0.4 \[[@RSOB160330C62]\]. Node sizes shown in the figures were proportional to the number of genes found in the gene set associated with the term.

5.8.. Individual strain analysis {#s5h}
--------------------------------

The BC~prot~ and PB~prot~ *cpa1Δ* strains were grown individually from a starting OD~600~ of 0.0625 to saturation in MM, SC, MM + uracil and MM + uracil + arginine (1.3×10^4^ mg ml^−1^) as shown in [figure 5](#RSOB160330F5){ref-type="fig"}*c* or as described for pooled growth.

5.9.. Library preparation {#s5i}
-------------------------

Bar-seq libraries were prepared using a custom two-step PCR approach using Phusion High-Fidelity DNA Polymerase (Thermo Fisher). First, uptags and downtags were separately amplified as described above for competitive fitness assays, but using primer pairs UP_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGATGTCCACGAGGTCTCT and UP_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTCGACCTGCAGCGTACG or DOWN_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGAAAACGAGCTCGAATTCATCG and DOWN_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCGGTGTCGGTCTCGTAG. Uptag and downtag PCRs were then pooled in equal amounts and purified using the GeneJET PCR purification kit according to the manufacturer\'s instructions (Thermo Fisher). Second, purified barcodes were diluted 1 : 10 and 1 µl was used as template in the second PCR using Nextera XT index primers (Illumina), which contain individual barcodes as well as Illumina adapters. Cycling conditions were as follows: 98°C for 30 s; eight cycles of 98°C for 10 s, 55°C for 30 s, 72°C for 15 s; 72°C for 5 min. Libraries were then purified using Agencourt AMPure XP beads (Beckman Coulter) at a ratio of 3 : 5 beads to DNA, checked on Agilent High Sensitivity DNA chips for the Bioanalyzer (Agilent) and quantified using Quant-iT high sensitivity dsDNA Assay kit (Thermo Fisher). Pooled sequencing libraries were sequenced on a HiSeq 2500 (Illumina) in rapid run mode, generating paired or single-end 100 bp reads.

5.10.. Bar-seq analysis {#s5j}
-----------------------

For the Bar-seq libraries sequenced with a paired-read protocol, the read mates were merged into single reads using BBM[erge]{.smallcaps} v. 8.82 from the BBT[ools]{.smallcaps}/BBM[ap]{.smallcaps} analysis suite (<https://sourceforge.net/projects/bbmap/>). Following that preliminary step, the same analysis procedure was then used on the reads originating from all the libraries, sequenced with paired or single-read protocols. Briefly, Bar-seq single sequence reads were first trimmed to 50 bases with T[rimmomatic]{.smallcaps} v. 0.33 \[[@RSOB160330C63]\] and then mapped to a yeast barcode database using the short-read aligner BWA v. 0.7.12 \[[@RSOB160330C64]\]. The BWA database was built using the barcode information from Pierce *et al.* \[[@RSOB160330C27]\] with the concatenation of barcode primer sequences at both ends of the barcodes specific for the uptags and downtags. Filtering of the aligned reads was performed with the SAM[tools]{.smallcaps} toolbox v. 1.2 \[[@RSOB160330C65]\], keeping only reads with mapping quality of 30 and above. Reads were counted for each library with the help of the BEDT[ools]{.smallcaps} suite v. 2.24 \[[@RSOB160330C66]\] and a matrix of counts was created for the whole dataset with a custom-made Perl script for downstream statistical analysis. After filtering for tags that had greater than or equal to 50 counts across all control replicates, uptags and downtags for each strain were summed, normalized and analysed with the [edge]{.smallcaps}R package v. 3.10.5 \[[@RSOB160330C67]\] as previously described \[[@RSOB160330C28]\].
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